Drug Safety Newsletter – Edition 123 – 13 July 2026
13/07/2026
Medicines for human use
Safety update
The latest edition of the HPRA newsletter includes important updates to support the safe and appropriate use of the following medicines:
- Methylphenidate: New warning regarding increased intraocular pressure and glaucoma
- Topical minoxidil: New warning of hypertrichosis associated with inadvertent exposure in children
- Mysimba (naltrexone hydrochloride / bupropion hydrochloride): Interaction with opioids
- Product information updates recommended by the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC)
- Direct Healthcare Professional Communications published on the HPRA website since the last Drug Safety Newsletter